DZD-1516 | m-entrepreneurship.com

Product Name :
DZD-1516

Search keywords :
DZD1516

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-2

Target Vo Short Name :
HER2

Moa_Name:
Receptor protein-tyrosine kinase erbB-2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Dizal (Jiangsu) Pharmaceutical Co Ltd

Active Company_Name :
Dizal (Jiangsu) Pharmaceutical Co Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PI3 Kinase p85 alpha (Y10P61) Mouse mAb In Vivo
Cyclin B1 Rabbit pAb custom synthesis
IDH1 Antibody: IDH1 Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-IDH1 monoclonal antibody. IDH1 Antibody can be used for: WB, IHC-P, IP expriments in human, mouse, rat background without labeling.

Author: Betaine hydrochloride

Related Posts